The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characterization of hyperprogressive disease in patients with advanced biliary tract cancer treated with anti-PD-1 inhibitor: A multicenter retrospective study.
 
Choong-kun Lee
No Relationships to Disclose
 
Jaekyung Cheon
No Relationships to Disclose
 
Eo Jin Kim
No Relationships to Disclose
 
Chang Gon Kim
No Relationships to Disclose
 
Sunkyu Kim
No Relationships to Disclose
 
Chan Kim
No Relationships to Disclose
 
Beodeul Kang
No Relationships to Disclose
 
Hye Jin Choi
No Relationships to Disclose
 
Changhoon Yoo
Stock and Other Ownership Interests - Oncocross
Honoraria - Bayer; Ipsen; SERVIER
Consulting or Advisory Role - LSK BioPharma
Speakers' Bureau - Bayer; Celgene; Eisai; Ipsen; Merck Sharp & Dohme
Research Funding - AstraZeneca; Bayer; CKD pharm; SERVIER
 
Hong Jae Chon
No Relationships to Disclose